Status | Study |
Completed |
Study Name: Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorder Condition: Post-transplant Lymphoproliferative Disorder Recurrent Adult Burkitt Lymphoma Date: 2003-07-08 Interventions: Biological: rituximab Given IV |
Terminated |
Study Name: Reduced Immunosuppressive Therapy With or Without Donor White Blood Cells in Treating Patients With Lymphoproliferative Disease After Organ Transplantation Condition: Lymphoproliferative Disorder Date: 2002-04-09 Interventions: Biological: therapeutic allogeneic lymphocytes |